212.26
前日終値:
$208.06
開ける:
$209.71
24時間の取引高:
1.21M
Relative Volume:
1.29
時価総額:
$13.32B
収益:
$4.27B
当期純損益:
$-356.15M
株価収益率:
-35.55
EPS:
-5.9702
ネットキャッシュフロー:
$1.19B
1週間 パフォーマンス:
+4.06%
1か月 パフォーマンス:
+13.54%
6か月 パフォーマンス:
+54.69%
1年 パフォーマンス:
+79.59%
Jazz Pharmaceuticals Plc Stock (JAZZ) Company Profile
名前
Jazz Pharmaceuticals Plc
セクター
電話
353-1-634-7800
住所
FIFTH FLOOR, WATERLOO EXCHANGE, DUBLIN
Compare JAZZ vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
JAZZ
Jazz Pharmaceuticals Plc
|
212.26 | 13.05B | 4.27B | -356.15M | 1.19B | -5.9702 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 109.34B | 12.32B | 4.34B | 3.19B | 16.86 |
|
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 74.35B | 14.92B | 4.42B | 3.79B | 41.04 |
|
ARGX
Argen X Se Adr
|
794.70 | 50.44B | 4.16B | 1.29B | 734.26M | 19.58 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 39.78B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.02B | 5.36B | 287.73M | 924.18M | 2.5229 |
Jazz Pharmaceuticals Plc Stock (JAZZ) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-10 | 再開されました | Raymond James | Outperform |
| 2026-02-27 | 開始されました | Barclays | Overweight |
| 2025-11-24 | ダウングレード | UBS | Buy → Neutral |
| 2025-07-15 | 開始されました | Deutsche Bank | Buy |
| 2025-03-07 | アップグレード | UBS | Neutral → Buy |
| 2025-02-26 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2025-02-13 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2024-12-12 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2024-06-05 | 開始されました | Goldman | Buy |
| 2024-01-03 | 開始されました | Robert W. Baird | Outperform |
| 2023-11-27 | ダウングレード | UBS | Buy → Neutral |
| 2023-09-29 | 開始されました | Raymond James | Mkt Perform |
| 2023-06-12 | 再開されました | Wells Fargo | Equal Weight |
| 2022-12-09 | アップグレード | Goldman | Neutral → Buy |
| 2022-06-14 | 開始されました | UBS | Buy |
| 2022-04-06 | ダウングレード | Goldman | Buy → Neutral |
| 2021-11-19 | 再開されました | Goldman | Buy |
| 2021-10-07 | 再開されました | Jefferies | Buy |
| 2021-10-05 | 開始されました | Citigroup | Buy |
| 2021-09-23 | 開始されました | Needham | Buy |
| 2021-05-19 | 再開されました | JP Morgan | Overweight |
| 2021-04-07 | 再開されました | RBC Capital Mkts | Outperform |
| 2021-02-05 | 繰り返されました | H.C. Wainwright | Buy |
| 2021-02-03 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2021-01-29 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-16 | 開始されました | UBS | Buy |
| 2020-11-03 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-10-09 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-09-14 | ダウングレード | Goldman | Neutral → Sell |
| 2020-09-14 | 再開されました | JP Morgan | Overweight |
| 2020-08-06 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2020-07-28 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2020-07-23 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2020-04-06 | 開始されました | Jefferies | Buy |
| 2020-03-12 | アップグレード | Bernstein | Mkt Perform → Outperform |
| 2020-01-08 | 開始されました | Goldman | Neutral |
| 2019-08-21 | ダウングレード | Piper Jaffray | Overweight → Neutral |
| 2019-06-11 | 開始されました | Barclays | Overweight |
| 2019-03-20 | 開始されました | SunTrust | Buy |
| 2018-12-14 | 開始されました | Wolfe Research | Peer Perform |
| 2018-11-08 | 繰り返されました | B. Riley FBR | Buy |
| 2018-08-08 | 繰り返されました | Stifel | Buy |
| 2018-07-11 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2018-03-23 | 繰り返されました | H.C. Wainwright | Neutral |
| 2018-03-19 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
すべてを表示
Jazz Pharmaceuticals Plc (JAZZ) 最新ニュース
Jazz Pharmaceuticals Q1 Earnings Call Highlights - Yahoo Finance
Jazz (JAZZ) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance Singapore
Jazz Pharmaceuticals (JAZZ) Q1 Earnings and Revenues Top Estimates - Yahoo Finance Singapore
Earnings call transcript: Jazz Pharmaceuticals Q1 2026 earnings beat expectations By Investing.com - Investing.com Canada
Jazz Pharmaceuticals plc 2026 Q1ResultsEarnings Call Presentation (NASDAQ:JAZZ) 2026-05-05 - Seeking Alpha
Jazz Pharmaceuticals Q1 2026 Earnings Call: Complete Transcript - Benzinga
Jazz Pharmaceuticals surges on earnings beat, strong revenue By Investing.com - Investing.com South Africa
Jazz Pharmaceuticals surges on earnings beat, strong revenue - Investing.com
Jazz Pharmaceuticals (NASDAQ:JAZZ) Surges 3.7% After-Hours on Q1 2026 Revenue and EPS Beat - ChartMill
Jazz: Q1 Earnings Snapshot - wwltv.com
(JAZZ) Jazz Pharmaceuticals Expects Full Year 2026 Revenue Range $4.25B$4.50B, vs. FactSet Est of $4.44B - marketscreener.com
Bruce Cozadd sells 6,000 Jazz (NASDAQ: JAZZ) shares under 10b5-1 plan - Stock Titan
Earnings Flash (JAZZ) Jazz Pharmaceuticals plc Reports Q1 Revenue $1.07B, vs. FactSet Est of $978.5M - marketscreener.com
Jazz Pharmaceuticals (NASDAQ:JAZZ) Surprises With Q1 CY2026 Sales - Yahoo Finance
Earnings Flash (JAZZ) Jazz Pharmaceuticals plc Posts Q1 Adjusted EPS $6.34 per Share - marketscreener.com
Jazz Pharmaceuticals (NASDAQ: JAZZ) swings to Q1 2026 profit on PRV sale - Stock Titan
Jazz Pharmaceuticals (NASDAQ: JAZZ) posts 19% Q1 revenue growth - Stock Titan
Jazz Pharmaceuticals Announces First Quarter 2026 Financial Results - PR Newswire
All eyes on Jazz Pharmaceuticals earnings as FDA decision nears By Investing.com - Investing.com Canada
All eyes on Jazz Pharmaceuticals earnings as FDA decision nears - Investing.com
MSN Money - MSN
Jazz Pharmaceuticals stock hits all-time high at 207.49 USD By Investing.com - Investing.com India
Jazz Pharmaceuticals stock hits all-time high at 207.49 USD - Investing.com
Jazz Pharmaceuticals (JAZZ) Q1 Earnings Report Preview: What To Look For - Yahoo Finance
Jazz Pharmaceuticals PLC $JAZZ Shares Sold by Mitsubishi UFJ Trust & Banking Corp - MarketBeat
A Look At Jazz Pharmaceuticals (JAZZ) Valuation After Ziihera Priority Review Milestone - simplywall.st
Jazz Pharmaceuticals (NASDAQ: JAZZ) reports two 6,000-share Rule 144 sales - Stock Titan
JAZZ Forecast, Price Target & Analyst Ratings | JAZZ PHARMACEUTICALS PLC (NASDAQ:JAZZ) - ChartMill
Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Sees Significant Decline in Short Interest - MarketBeat
Vanguard Capital Management reports 5.04% stake in Jazz Pharmaceuticals (NASDAQ: JAZZ) - Stock Titan
Will Ziihera’s Priority Review in First-Line HER2-Positive Gastric Cancer Shift Jazz Pharmaceuticals’ (JAZZ) Narrative? - simplywall.st
Pictet Asset Management Holding SA Sells 33,547 Shares of Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
M&T Bank Corp Purchases New Shares in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
US Cannabis Market Report Analysis Report 2026-2034 Featuring Canopy Growth, Tilray Brands, Curaleaf, Aurora Cannabis, Jazz Pharma, GTI, Trulieve, Cresco Labs, Organigram Global, TerrAscend - Yahoo Finance
Jazz Pharmaceuticals (JAZZ) Projected to Post Quarterly Earnings on Tuesday - MarketBeat
Market Driver Insights: The Impact of Recent Developments on the Erwinaze/Spectrila Market - openPR.com
FDA accepts Jazz Pharma filing for Ziihera in gastric cancer By Investing.com - Investing.com South Africa
FDA accepts Jazz Pharma filing for Ziihera in gastric cancer - Investing.com UK
Wells Fargo Maintains Jazz Pharmaceuticals (JAZZ) Overweight Recommendation - MSN
How ASCO Phase 3 Oncology Data May Reshape Jazz Pharmaceuticals' (JAZZ) Investment Narrative - Yahoo Finance
Unpacking Q4 Earnings: Jazz Pharmaceuticals (NASDAQ:JAZZ) In The Context Of Other Pharmaceuticals Stocks - Yahoo Finance
Jazz Pharmaceuticals announces FDA acceptance and Priority Review of supplemental biologics license application for Ziihera - marketscreener.com
Jazz Pharmaceuticals Announces FDA Acceptance and Priority Review of Supplemental Biologics License Application for Ziihera® (zanidatamab-hrii) Combinations in First-Line HER2+ Locally Advanced or Metastatic GEA - PR Newswire
Jazz Pharmaceuticals (JAZZ) Stock Analysis: A Biotech Powerhouse with a 14.76% Upside Potential - DirectorsTalk Interviews
Jazz Pharmaceuticals enters exclusive licensing deal with Saniona - msn.com
Universal Beteiligungs und Servicegesellschaft mbH Has $15.32 Million Stock Holdings in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Polaris Capital Management LLC Sells 81,000 Shares of Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Jazz Pharmaceuticals Executive Compensation Program 2025: Structure, Philosophy, and Key Features Explained - Minichart
Jazz Pharmaceuticals to Participate in the BofA Securities 2025 Healthcare Conference - 富途牛牛
Jazz Pharmaceuticals (NASDAQ: JAZZ) details 2025 pay, board and pipeline - Stock Titan
Assessing Jazz Pharmaceuticals (JAZZ) Valuation After Oncology Data, Cannabis Shift And Modeyso Royalty News - simplywall.st
Jazz Pharmaceuticals Plc (JAZZ) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):